These uses of GLP-1RA beyond the proven use in treatment and prevention of cardiovascular risk with obesity (110) as well as in diabetics add a new dimension to use them in early
But language in distributor pitches has invoked Protandims purported ability to repair damage from the virus, or supposed adverse effects from the vaccines
Comparing Clinical Evidence: GLP-1 Receptor Agonists vs Antioxidant Therapy Randomized controlled trials of semaglutide, including SUSTAIN and STEP studies, consistently show significant weight loss, improved blood sugar control, and reduced cardiovascular risk markers
In this video, Alex shares her real experience, from the decision to undergo bariatric surgery to the amazing results she enjoys today
According to clinical studies by the National Library of Medicine, those taking Semaglutide noticed "less appetite and food cravings, better control of eating and lower relative preference for fatty, energydense foods" after 12 weeks of treatment